Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Placebo Controlled Study of the Safety of 3% w/w SPL7013 Gel, Administered to the Penis of Healthy Male Volunteers Once Daily for Seven Days

NCT00370357 is registered in ClinicalTrials.gov with Starpharma Pty Ltd as lead sponsor.

NCT NCT00370357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00370357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Placebo Controlled Study of the Safety of 3% w/w SPL7013 Gel, Administered to the Penis of Healthy Male Volunteers Once Daily for Seven Days
Lead sponsor
Starpharma Pty Ltd
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2006
Completion date
June 30, 2007
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)